In the United States, Angelina Jolie’s decision to share her experience with the increased risk of breast and ovarian cancer due to BRCA1 gene mutations has improved public awareness of the disease and increased genetic testing and breast cancer screening. Here, BRCA1 is linked to breast carcinoma.